Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• The Cannabis Frontier: As Medical Cannabis Moves Mainstream, are Gastroenterologists Prepared?
• FDA Accepts Application for Subcutaneous Entyvio for UC
• FDA Approves Mavyret for all HCV Genotypes in Children
• FDA Approves Non-surgical Weight Loss Device for Obesity
• Mallinckrodt Completes Phase 3 Enrollment for Hepatorenal Syndrome Drug
• RedHill Biopharma Submits NDA for H. pylori Therapy
• Phase 3 Trial of Selonsertib for NASH-fibrosis Reduction Fails to Meet Primary Endpoint
• Health Care ‘Cannot Bury its Head in the Sand Regarding Cannabis’ Any Longer
• Age Tied to Infection Risk in IBD
• Better Positioning has Improved Outcomes of Entyvio Therapy
• Certain Lesions at Resection Linked to Crohn's Recurrence
• Efficacy of Anti-TNFs Similar in Postoperative Crohn's Recurrence
• 'Every Patient, Every Time': Inpatient Protocol Standardizes UC Care
• Finding Consensus for Biologic TDM in IBD
• FMT Spurs 'Huge' Drop in Hospital Costs for Patients With C. diff
• Inpatient Bowel Prep can Improve With a Few Modifiable Factors
• It's Not Personal: Polyp Detection Better With Higher Volume, Recent Training
• Non-invasive Index Effectively Monitors Mucosal Healing in Pediatric Crohn's
• Patients With IBD Twice as Likely to Have Herpes Zoster
• Radiographic Features Predict Need to Resect Intraabdominal Abscesses in Crohn's
• Some Patients With IBD Need Thromboprophylaxis After Hospitalization
• Cannabis Use High in IBD, More Research Needed to Assess Therapeutic Effects
• 'Complicated' Relationship Exists Between IBS, Low FODMAP Diet
• Cooking Classes Improve Diet Adherence, Quality of Life in Celiac
• FMT Safe, Effective in Patients With IBD, C. diff Infection
• Highlights from Digestive Disease Week
• TDM Program Improves Clinical Outcomes in Pediatric IBD
• Young Adults Demonstrate Ability to Handle Their GI Medical Records
• International Research Effort May Yield New Insights into Microbiome’s Role in Colorectal Cancer
• Salix, Bausch Health Subsidiary Enter Deal to Develop Late-stage Therapy for IBD
• TV Ads Will Soon Start Showing Drug Prices